Vireo Health International (CNSX:VREO; OTCQX:VREOF) appointed Bruce Linton to the role of executive chairman, where he will serve as a director, work closely with Vireo CEO and founder, Dr. Kyle Kingsley, and spearhead the company’s strategic decision-making, capital markets activity and future partnerships.
Mr. Linton is the founder and former CEO of Canopy Growth (TSX:WEED, NYSE:CGC) and co-founder of Tweed Marijuana. Under Mr. Linton’s leadership, Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange and the first to list on the New York Stock Exchange.
“Beyond the attractive collection of strategic assets and intellectual property that Dr. Kingsley has assembled, I have taken this role because I share the company’s ambitious vision for the future of cannabis,” Mr. Linton said in a statement.
“We are confident Vireo can become a top U.S. producer and distributor of high-margin, proprietary products within the next several years and create unprecedented long-term shareholder value,” he added.
Dr. Kingsley said there is no greater endorsement than Bruce Linton joining as executive chairman. “Bruce’s extraordinary track record in the cannabis industry speaks for itself and I am incredibly excited about the opportunity to work closely with this industry trailblazer.”
